Internal Medicine, Rheumatology · Chicago, IL
NPI
1871785667
Since 2007
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1801 W Taylor St
Chicago, IL, 60612
Phone (312) 413-9310
Groups this clinician bills Medicare through
Medicare paid, 2024
$13K
249 services
Medicare patients, 2024
79
Average age 68
Drug cost, 2024
$1.5M
836 prescriptions
Company payments, 2025
$86.51
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Pim Jetanalin was code 99214 (office e&m - established), 96 times for 56 patients. In total Pim Jetanalin billed 249 services in 16 codes, and Medicare paid $13K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-06-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 96 | 56 | $68.07 | $6,535 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 61 | 41 | $13.34 | $814 |
| 20610 Joint Injection | Facility | 39 | 22 | $40.12 | $1,565 |
| 99215 Office E&M - Established | Facility | 22 | 16 | $98.66 | $2,170 |
By year: 2022 $15K for 202 services; 2023 $13K for 182 services; 2024 $13K for 249 services.
Medicare prescription drug claims, 2024
In 2024, the drug Pim Jetanalin prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 118 prescriptions and refills. In total Pim Jetanalin wrote 836 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 118 | 240 | 36 | $5,085 |
| Methotrexate Methotrexate Sodium | 84 | 125 | 20 | $1,665 |
| Prednisone Generic | 72 | 112 | 30 | $349 |
| Orencia Clickject Abatacept | 53 | 53 | Under 11 | $292K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 33 | 33 | Under 11 | $347 |
| Otrexup Methotrexate/Pf | 32 | 32 | Under 11 | $24K |
| Xeljanz Xr Tofacitinib Citrate | 31 | 31 | Under 11 | $161K |
| Gabapentin Generic | 30 | 66 | Under 11 | $678 |
| Humira Pen Adalimumab | 28 | 30 | Under 11 | $193K |
| Alendronate Sodium Generic | 27 | 32 | Under 11 | $44.52 |
| Benlysta Belimumab | 24 | 24 | Under 11 | $103K |
| Leflunomide Generic | 23 | 57 | Under 11 | $824 |
| Pregabalin Generic | 21 | 26 | Under 11 | $292 |
| Sulfasalazine Dr Sulfasalazine | 18 | 28 | Under 11 | $528 |
| Humira(Cf) Pen Adalimumab | 16 | 18 | Under 11 | $112K |
Brand drugs: - claims; generic drugs: 559 claims; opioid claims: 58.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pim Jetanalin $86.51 ($86.51 in general payments such as food, travel and fees) from 3 companies. The largest payer was UCB, Inc. with $42.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.